SCHEMBL16783097

SCHEMBL16783097

Cc1cc(C2CC2)ncc1-c1cc(C(=O)Nc2c(C)cncc2F)nn1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STIM1 Q13586 2/20 0.39
▸ ORAI1 Q96D31 2/20 0.39
▸ IDO1 P14902 1/20 0.37
▸ PDE4B Q07343 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ CRACR2A Q9BSW2 2/20 0.33
▸ EED O75530 1/20 0.33
▸ SUZ12 Q15022 1/20 0.33
▸ EZH2 Q15910 1/20 0.33
▸ KCNH2 Q12809 2/20 0.33
▸ ATR Q13535 2/20 0.33
▸ SSTR2 P30874 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ GRM5 P41594 1/20 0.32
▸ CHRNB2 P17787 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16782972 0.89 NPY5R (0.41) STIM1ORAI1IDO1NPC1RAB9A
SCHEMBL16783100 0.86 STIM1 (0.42) STIM1ORAI1PDE4BKDM4ECRACR2A
SCHEMBL16783020 0.85 PDE4B (0.40) STIM1ORAI1PDE4BKCNH2ATR
SCHEMBL16782952 0.83 STIM1 (0.43) STIM1ORAI1NPC1RAB9ASMN1; SMN2
SCHEMBL17376773 0.83 STIM1 (0.45) STIM1ORAI1IDO1PDE4BKDM4E
SCHEMBL16782962 0.83 STIM1 (0.38) STIM1ORAI1NPC1RAB9ASMN1; SMN2
SCHEMBL16783027 0.82 NPC1 (0.38) STIM1ORAI1NPC1RAB9ASMN1; SMN2
SCHEMBL16783095 0.81 RAB9A (0.42) STIM1ORAI1NPC1RAB9ASMN1; SMN2
SCHEMBL16782958 0.81 NPC1 (0.40) STIM1ORAI1PDE4BNPC1RAB9A
SCHEMBL16804963 0.81 ORAI1 (0.39) STIM1ORAI1PDE4BNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015090579-A1 PYRAZOLYL-BASED CARBOXAMIDES IV Grünenthal GmbH (DE) 2015-06-25 — — WO disclosed
WO-2015090579-A1 PYRAZOLYL-BASED CARBOXAMIDES IV Grünenthal GmbH (DE) 2015-06-25 — — WO disclosed
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US disclosed
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US disclosed
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES AADAC, NLRP3, NOD2 STIM1 1469/4885ORAI1 2913/4885IDO1 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback